EUVIMEDEUVIMED entdecken
Crossref

Clinical Worsening Despite Various Imunotherapy In Hashimoto-Antibodies-Associated-Encephalopathy

J. C. Bier, H. Slama, S. De Breucker, L. Victoor, S. Goldman, M. Vokaer

The Open Geriatric Medicine Journal · 2008

DOI: 10.2174/1874827900801010024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Open Geriatric Medicine Journal, 2008. Verfasst von J. C. Bier und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In 1966, first description of a "Steroid-Responsive Encephalopathy Associated with autoimmune Thyroiditis (SREAT)" syndrome was described.Since then, lots of cases emerged with two major kinds of presentations: "vasculitic" and "diffuse progressive".Patients respond variably to corticoids.Methotrexate, plasmatic exchange or intravenous imunoglobulins (IvIG) have only been anecdotically used.Case Report: A 63 years old man presented with mild words finding difficulties evolving for 5 years in 2000.He lost appetite and was tired despite sleeping 10 hours/day for 3 years.He presented bradypsychia and his MMSE was 28/30.Diagnosis of depression was made and treated.At this time, he fell asleep while eating or watching TV.EEGs and usual blood investigations were normal.During the next three years, he presented left extinction and extra-pyramidal gait followed by spontaneous myoclonus.Both lumbar puncture and brain MRI were normal despite atrophy.Diagnosis of cortical posterior atrophy due to possible corticobasal degeneration was then set up.Cognitive decline rapidly progressed and anti-TPO antibodies were positive at >3000 UI/ml.Treatment by oral methylprednisolone (64mg/day during 1 month) was then initiated and followed by a delirious major depressive disorder requiring hospitalization.Over the next years, cognitive decline persisted and treatments by methotrexate, prednisolone and even IvIG were all followed by worsening of myoclonus and psychosis relapses.

Conclusion

This case of clinical worsening after immunotherapy highlights the necessity to cautiously study the response of SREAT to immune-therapies.

Zitieren

APA

Bier, J. C., Slama, H., Breucker, S. D., Victoor, L., Goldman, S., & Vokaer, M. (2008). Clinical Worsening Despite Various Imunotherapy In Hashimoto-Antibodies-Associated-Encephalopathy. The Open Geriatric Medicine Journal. https://doi.org/10.2174/1874827900801010024

Vancouver

Bier JC, Slama H, Breucker SD, Victoor L, Goldman S, Vokaer M. Clinical Worsening Despite Various Imunotherapy In Hashimoto-Antibodies-Associated-Encephalopathy. The Open Geriatric Medicine Journal. 2008. doi:10.2174/1874827900801010024

BibTeX
@article{Bier2008,
  author = {Bier, J. C. and Slama, H. and Breucker, S. De and Victoor, L. and Goldman, S. and Vokaer, M.},
  title = {Clinical Worsening Despite Various Imunotherapy In Hashimoto-Antibodies-Associated-Encephalopathy},
  journal = {The Open Geriatric Medicine Journal},
  year = {2008},
  doi = {10.2174/1874827900801010024}
}
Kostenlos starten →